Loading
CP
Consun Pharmaceutical Group Ltd. Stock: price and insider trades · Hong Kong
HK·Mcap HK$13.1B
No insider purchase over the last 90 days. The latest, by Zhang Lihua, was filed 17 Jul 2025.
Consun Pharmaceutical Group Ltd.: what insiders have been doing
Consun Pharmaceutical Group Ltd. is a listed company. Its directors and officers file their transactions with HKEX. Nothing new has been filed by managers of Consun Pharmaceutical Group Ltd. in twelve months, the latest record being from 17 July 2025.
The full history, which starts in 2017, counts 72 purchases against 14 sales.
Elsewhere in the same market, our signals recently picked up insider purchases at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
93
Thresholds
n/a
Buy Volume
€16M
72 ops. · all time
Sell Volume
€992,880
14 ops. · all time
Who traded when
BuySaleAn Meng5 buys
Zhang Lihua5 buys
Since the insiders bought
- +11.0%Entry HK$12.38 · Close at T+365 HK$13.74
- +11.0%Entry HK$12.38 · Close at T+365 HK$13.74
- -4.0%Entry HK$3.51 · Close at T+365 HK$3.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 1,012 of 26,281 companies
80.6
score / 100
Value70
Quality91
FCF yld8.7%
Earn yld8.2%
EV/EBITDA10.5x
ROE24%
Gross mgn78%
Net mgn32%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
HK$15.68
Analyst consensus
3 analystsHK$19.31Target HK$22.73(+45%)HK$26.10
Income statement
RevenueHK$3.4B
Gross profitHK$2.7B78% margin
EBITDAHK$1.3B37% margin
Net incomeHK$1.1B32.3% margin
Valuation
PER (trailing)10.2x
PER (forward)9.8x
P/Book2.4x
Beta0.43
Balance sheet & cash
Market capHK$13.1B
Total debtHK$212.9M
Free Cash FlowHK$1.1B
Debt / Equity5%
Profitability & ownership
ROE24.4%
ROA12.6%
% insiders45.7%
% institutions24.2%
Last declaration on 17 July 2025
Declarations93 total
136,000 shares@ HK$11.552.9% of flowShareXHKGHKEX:DA20250717E00476
Canonical exit: 13 Oct 2025 (T+90)
50,000 shares@ HK$12.061.1% of flowShareXHKGHKEX:DA20250717E00477
Canonical exit: 15 Oct 2025 (T+90)
251,000 shares@ HK$11.365.2% of flowShareXHKGHKEX:DA20250712E00021
Canonical exit: 9 Oct 2025 (T+90)
27,000 shares@ HK$11.180.6% of flowShareXHKGHKEX:DA20250712E00020
Canonical exit: 8 Oct 2025 (T+90)
10,413,455 sharesShareXHKGHKEX:DA20250423E00411
Canonical exit: 22 Jul 2025 (T+90)
92,000 shares@ HK$5.941.1% of flowShareXHKGHKEX:DA20240919E00035
Canonical exit: 16 Dec 2024 (T+90)
350,000 shares@ HK$5.783.9% of flowShareXHKGHKEX:DA20240919E00034
Canonical exit: 15 Dec 2024 (T+90)
295,000 shares@ HK$5.803.3% of flowShareXHKGHKEX:DA20240913E00409
Canonical exit: 12 Dec 2024 (T+90)
856,000 shares@ HK$5.679.5% of flowShareXHKGHKEX:DA20240913E00408
Canonical exit: 11 Dec 2024 (T+90)
1,021,000 shares@ HK$5.6411.3% of flowShareXHKGHKEX:DA20240913E00321
Canonical exit: 10 Dec 2024 (T+90)
518,000 shares@ HK$5.575.7% of flowShareXHKGHKEX:DA20240913E00317
Canonical exit: 9 Dec 2024 (T+90)
290,000 shares@ HK$5.283.0% of flowShareXHKGHKEX:DA20240909E00211
Canonical exit: 4 Dec 2024 (T+90)
25 of 93 declarations
About Consun Pharmaceutical Group Ltd.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations